Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20822718 | 0.99 | HSP90AA1 (0.33) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL15713747 | 0.97 | PLA2G2A (0.36) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL24647205 | 0.97 | PLA2G2A (0.33) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL20824262 | 0.96 | PLA2G2A (0.32) | HSP90AA1HSP90AB1PLA2G2APLA2G4APDK2 | |
| SCHEMBL20823631 | 0.96 | KDM4E (0.33) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL20824223 | 0.96 | KDM4E (0.33) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL20823059 | 0.95 | MMP12 (0.32) | AHRKDM4EMEN1NPC1ALDH1A1 | |
| SCHEMBL24647058 | 0.94 | PLA2G2A (0.34) | HSP90AA1HSP90AB1PLA2G2APLA2G4APDK2 | |
| SCHEMBL24229093 | 0.94 | AHR (0.32) | HSP90AA1HSP90AB1AHRKDM4EMEN1 | |
| SCHEMBL20822645 | 0.94 | MMP12 (0.33) | AHRKDM4EMEN1NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663288-B1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2022-06-08 | — | — | EP | disclosed |
| EP-3663288-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190088879-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICES, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | HSP90AA1 4531/4885HSP90AB1 4765/4885AHR 1338/4885 |
| US-10424740-B2 | Compound, material for organic electroluminescence devices, organic electroluminescence device, and electronic device | PIEZO1, LEF1, L1CAM | HSP90AA1 4531/4885HSP90AB1 4765/4885AHR 1338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.